Displaying 73 - 84 of 119
Viral Hepatitis
5

Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021

View
Viral Hepatitis
5

Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021

View
Viral Hepatitis
5

Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021

View
Viral Hepatitis
5

Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021

View
Viral Hepatitis
5

Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
5

International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
5

International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
5

International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
5

International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View
Displaying 73 - 84 of 119